Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
PUT
CSX Corp
CSX
$92.8B
| $1.77M | ﹤0.01% |
60,000
| – | – |
|
2677
Columbus McKinnon
CMCO
$550M
| $1.76M | ﹤0.01% |
104,017
+51,080
| +96% | +$1.33M |
|
2678
DigitalBridge
DBRG
$2.95B
| $1.76M | ﹤0.01% |
199,193
-79,966
| -29% | -$840K |
|
|
DMC
2679
Del Monte Corp
DMC
$1.42B
| $1.76M | ﹤0.01% |
56,928
-9,845
| -15% | -$302K |
|
2680
Pediatrix Medical
MD
$2.15B
| $1.75M | ﹤0.01% |
121,107
-30,309
| -20% | -$431K |
|
|
TWO
2681
Two Harbors Investment
TWO
$1.27B
| $1.75M | ﹤0.01% |
131,294
-51,207
| -28% | -$663K |
|
2682
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $1.75M | ﹤0.01% |
19,361
-12,685
| -40% | -$1.15M |
|
2683
Century Aluminum
CENX
$4.59B
| $1.75M | ﹤0.01% |
94,453
-5,465
| -5% | -$105K |
|
|
GRP.U
2684
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $1.75M | ﹤0.01% |
37,385
+12,561
| +51% | +$599K |
|
2685
Vanguard Total World Stock ETF
VT
$81.9B
| $1.75M | ﹤0.01% |
15,050
| – | – |
|
2686
QCR Holdings
QCRH
$1.73B
| $1.74M | ﹤0.01% |
24,375
-8,999
| -27% | -$686K |
|
2687
Bank of N.T. Butterfield & Son
NTB
$2.5B
| $1.74M | ﹤0.01% |
44,621
-22,141
| -33% | -$838K |
|
2688
Credit Acceptance
CACC
$6.05B
| $1.73M | ﹤0.01% |
3,351
-16,412
| -83% | -$8.12M |
|
2689
NeoGenomics
NEO
$2.11B
| $1.72M | ﹤0.01% |
181,666
-57,772
| -24% | -$721K |
|
2690
Healthcare Services Group
HCSG
$1.43B
| $1.72M | ﹤0.01% |
170,807
+11,398
| +7% | +$125K |
|
2691
Nurix Therapeutics
NRIX
$2.76B
| $1.72M | ﹤0.01% |
144,775
-4,561
| -3% | -$76.3K |
|
2692
Core Scientific
CORZ
$6.36B
| $1.72M | ﹤0.01% |
237,413
-788,154
| -77% | -$8.97M |
|
|
JBGS
2693
JBG SMITH
JBGS
$692M
| $1.72M | ﹤0.01% |
106,509
-40,294
| -27% | -$613K |
|
2694
CRA International
CRAI
$1.07B
| $1.71M | ﹤0.01% |
9,869
-3,040
| -24% | -$563K |
|
2695
Preferred Bank
PFBC
$1.26B
| $1.71M | ﹤0.01% |
20,408
-6,600
| -24% | -$572K |
|
2696
Intellia Therapeutics
NTLA
$1.66B
| $1.71M | ﹤0.01% |
240,096
-71,536
| -23% | -$723K |
|
2697
Community Health Systems
CYH
$410M
| $1.71M | ﹤0.01% |
631,550
-206,793
| -25% | -$644K |
|
2698
CareDx
CDNA
$2.45B
| $1.7M | ﹤0.01% |
96,000
-16,076
| -14% | -$346K |
|
|
SKX
2699
CALL
DELISTED
Skechers
SKX
| $1.7M | ﹤0.01% |
30,000
-270,000
| -90% | -$17.6M |
|
2700
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $1.7M | ﹤0.01% |
37,608
+37,000
| +6,086% | +$1.67M |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.